Skip to main content

Peri-implantitis

0
Pipeline Programs
5
Companies
5
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

5 companies ranked by most advanced pipeline stage

Altay Therapeutics
Altay TherapeuticsCA - San Carlos
2 programs
Debridement of implant surface with titanium curettes and irrigation with sterile saline solutionN/A1 trial
UnknownN/A
Active Trials
NCT06810401Completed63Est. Oct 2024
Biolase
BiolaseCA - Foothill Ranch
1 program
Er,Cr:YSGG laserN/A1 trial
Active Trials
NCT03544515Completed32Est. Aug 2021
Geistlich Pharma
Geistlich PharmaSwitzerland - Root
1 program
GBO and GBGN/A1 trial
Active Trials
NCT02375750Completed71Est. Apr 2017
SigmaGraft
SigmaGraftCA - Fullerton
1 program
InterOss CollagenN/A1 trial
Active Trials
NCT05699343Enrolling By Invitation52Est. Dec 2028
Heidelberg Pharma
Heidelberg PharmaGermany - Ladenburg
1 program
Air abrasion of the implant surface with a low abrasive powderPHASE_21 trial
Active Trials
NCT01256996Unknown40Est. Jan 2012

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
Heidelberg PharmaAir abrasion of the implant surface with a low abrasive powder
Altay TherapeuticsDebridement of implant surface with titanium curettes and irrigation with sterile saline solution
SigmaGraftInterOss Collagen
BiolaseEr,Cr:YSGG laser
Geistlich PharmaGBO and GBG

Clinical Trials (5)

Total enrollment: 258 patients across 5 trials

NCT01256996Heidelberg PharmaAir abrasion of the implant surface with a low abrasive powder

Therapy of Peri-implantitis: Scaling Versus Low Abrasive Powder

Start: Jan 2011Est. completion: Jan 201240 patients
Phase 2Unknown
NCT06810401Altay TherapeuticsDebridement of implant surface with titanium curettes and irrigation with sterile saline solution

Effect of Smoking on Macrophage-related Chemokines Before and After Non-surgical Treatment of Initial Peri-implantitis

Start: Apr 2024Est. completion: Oct 202463 patients
N/ACompleted
NCT05699343SigmaGraftInterOss Collagen

Surgical Treatment of Peri-implantitis Using a Bone Substitute With or Without a Resorbable Collagen Membrane

Start: Jan 2023Est. completion: Dec 202852 patients
N/AEnrolling By Invitation
NCT03544515BiolaseEr,Cr:YSGG laser

Peri-implantitis Treatment: Clinical Results of Conventional Treatment vs. the Addition of Biolase

Start: Jan 2019Est. completion: Aug 202132 patients
N/ACompleted
NCT02375750Geistlich PharmaGBO and GBG

Treatment of Peri-implantitis Lesions by Using Biomaterial

Start: Sep 2014Est. completion: Apr 201771 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

5 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.